| Financial Year |
March 31 2023 |
| Monetary Funds |
340,021,258.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
91,746,293.05 |
| Accounts Receivable |
1,148,318,855.69 |
| Advances to Suppliers |
6,993,264.84 |
| Other Receivables |
58,923,252.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
438,867,573.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,272,041.32 |
| Total Current Assets |
2,134,552,974.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,668,582.01 |
| Investment Properties |
-- |
| Fixed Assetes |
48,492,993.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,433,517.34 |
| R&D expenses |
-- |
| Goodwill |
17,755,310.54 |
| Long-Term Deferred and Prepaid Expenses |
811,425.10 |
| Deferred Income Tax Assets |
59,222,778.64 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
360,361,227.56 |
| Total Assets |
2,494,914,201.74 |
| Short-Term Loans |
115,159,459.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,835,154.47 |
| Accounts Payable |
52,854,619.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,616,154.74 |
| Taxes Payable |
100,372,457.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,088,232.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,036,162.84 |
| Other Current Liabilities |
4,955,993.41 |
| Sub-Total of Current Liabilities |
423,746,247.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,307,572.42 |
| Total Liabilities |
430,053,820.17 |
| Paid-In Capital(Or Share Stock) |
599,855,469.00 |
| Capital Surplus |
453,649,497.67 |
| Surplus Reserve |
120,538,849.43 |
| LESS:Treasury Stock |
4,166,904.00 |
| Undistributed Profits |
809,128,252.06 |
| Minority Stockholder's Interest |
95,557,909.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,969,302,471.98 |
| Owner's Equity（Stockholder's Equity） |
2,064,860,381.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,494,914,201.74 |
